Becton, Dickinson - Strategy, SWOT and Corporate Finance Report
Summary
Becton, Dickinson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Key Highlights
Becton, Dickinson and Company (BD) is a global medical technology company. It is engaged in the development, manufacturing and sale of medical devices, laboratory equipment and diagnostic products. The company’s major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing systems; respiratory ventilation and diagnostics equipment; diagnostics specimens; instruments to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company operates across the Americas, Europe, Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.
Scope
Reasons to buy
Summary
Becton, Dickinson - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360° view of the company.
Key Highlights
Becton, Dickinson and Company (BD) is a global medical technology company. It is engaged in the development, manufacturing and sale of medical devices, laboratory equipment and diagnostic products. The company’s major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing systems; respiratory ventilation and diagnostics equipment; diagnostics specimens; instruments to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company operates across the Americas, Europe, Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.
Scope
- Detailed information on Becton, Dickinson required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Becton, Dickinson in the form of a SWOT analysis
- An in-depth view of the business model of Becton, Dickinson including a breakdown and examination of key business segments
- Intelligence on Becton, Dickinson 's mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Becton, Dickinson , such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
- Gain understanding of Becton, Dickinson and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Becton, Dickinson as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Becton, Dickinson 's business structure, strategy and prospects.
Table of Contents
Company Snapshot
Appendix
Methodology
List Of Tables
List of Figures
